IL17RC and acute lymphoblastic leukemia: Similarly, in the dominant and over‐dominant model, the IL‐17RC rs76999397 G/A polymorphism was linked to an increased risk of ALL (GG vs. AG + AA: OR = 60.27, 95% CI = 24.45–148.56, p < 0.0001; GG + AA vs. AG: OR = 52.82, 95% CI = 22.07–126.40, p < 0.0001).